Journal
JOURNAL OF SMALL ANIMAL PRACTICE
Volume 51, Issue 10, Pages 534-539Publisher
WILEY
DOI: 10.1111/j.1748-5827.2010.00987.x
Keywords
-
Categories
Funding
- BSAVA
- University of Bristol
- Pfizer
- PetBloodBank UK
- Frances Dunn (Highcroft Veterinary Group)
Ask authors/readers for more resources
OBJECTIVE: The aim of this study was to investigate whether the two canine haemoplasma species, Mycoplasma haemocanis and Candidatus Mycoplasma haematoparvum, are commonly associated with immune-mediated haemolytic anaemia (IMHA) in UK dogs. METHODS: Three groups of dogs were recruited to the study: anaemic dogs with primary IMHA (n=37); anaemic dogs not meeting the inclusion criteria for primary IMHA (n=77) and non-anaemic dogs (n=113). DNA was extracted from 100 mu l of blood and subjected to real-time quantitative polymerase chain reaction (qPCR) assays for both species of Mycoplasma. Each assay incorporated co-amplification of canine glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an endogenous internal control. RESULTS: Canine GAPDH was successfully amplified by qPCR from all 227 canine blood samples but none contained M. haemocanis or Candidatus M. haematoparvum DNA. CLINICAL SIGNIFICANCE: Haemoplasma infection is uncommon in dogs in the UK and no evidence was found that these organisms act as triggers for IMHA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available